RE: RE RE- LAST WORD1 Feb 2022 18:55
On the contrary, selling at around £1.30 region would allow one to pocket any profit plus the original stake. IMO it is worth missing the gap that would be between 30p to over £1 if FDA happens. I know of two people that will invest in this only after it has derisked and they would not hesitate to pay full premium, in fact they argue strongly for doing so. Think of it this way, when this is sold, the buyer will not be worrying about getting in at £1.10. They will likely pay way over £5.00.
After holding for a long time I have traded this twice over. Not because I think I am clever but because I understand the risk FDA presents or even economic disruption would have to my profit.
I still believe and I will be holding this at lift off. If I am not on board at lift off then I will pay the premium having discounted that considerably. After POLX I see no other way with regulatory approval plays.
I hope this does not influence anybody or disrupt your thinking. I don’t have as much money as some and could not leave profits swinging.